X

Emmessar Biotech & Nutrition Ltd. Stock Analysis

Small Cap
Evaluated by 145 users | BSE: 524768 | NSE: |
Pharmaceuticals & Drugs
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on  March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed -7.47%-11.88%-0.29%-8.83%-16.99%-7.97%15.68%79.06%36.06%22.38%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 5.83.93.20.61.42.222.61.30.6
Y-o-Y Gr. Rt.--32.7%-17.7%-81.9%136.2%59.9%-10.1%33.5%-52.5%-49.6%
Adjusted EPS (Rs.) -0.39-0.55-0.02-0.36-0.6-0.240.362.361.831.47
Y-o-Y Gr. Rt.-NANANANANANA555.6%-22.5%-19.7%
Book Value per Share (Rs.) 4.764.24.153.783.162.751.824.185.977.02
Adjusted Net Profit -0.2-0.30-0.2-0.3-0.10.21.20.90.7
Net Op. Cash Flow (Rs. Cr.) 0-0.100000.40.80.70.4
Debt to Cash Flow from Ops 0000000000.18
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Emmessar Biotech & Nutrition Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -21.8%-14.4%-31.6%-49.6%
Adjusted EPS NANA59.8%-19.7%
Book Value per Share 4.417.356.817.6
Share Price 22.5% 11.5% -8.4% 118.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) -7.68-11.98-0.38-8.9-17.08-8.0815.678.583622.6
Operating Profit Margin (%) -2.46-7.580.05-32.94-3.92-6.540.638.64-33.25-101.55
Net Profit Margin (%) -3.34-7.08-0.26-31.36-22.04-5.459.0244.7572.9116.54
Debt to Equity 0000000000.02
Working Capital Days 391503071,828477126175152333905
Cash Conversion Cycle 1115143627663644039187
Entity Percentage Holding
Promoters 58.46%
Institutions 0.20%
Non-Institutions 41.35%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Emmessar Biotech & Nutrition Ltd.'s performance infers:

Emmessar Biotech & Nutrition Ltd. earnings have grown by 0%, whereas share price has appreciated 11.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Emmessar Biotech & Nutrition Ltd. share prices over the last 10 years. Here is what we found out:

Emmessar Biotech & Nutrition Ltd. share price has appreciated 13% annually over the past ten years.

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on  March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on  January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on  March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on  January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products

  • Calmcream 
  • Magicream 
  • Supportt Joint  
  • Supportt Bones
  • Micro Nutrients 
  • Speciality Chemicals
  • CC-99  
  • Biosulf  
  • Calmcream  

Products planned to be launched in future

  • Ayurvedic Creams  
  • Nutraceutical Creams
  • Cosmeceutical Creams  
  • Oral Supplements  
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback